XBIT Stock Analysis: Buy, Sell, or Hold?
XBIT - XBiotech Inc
$2.36
-0.01 (-0.42%)
▼
5d:
-2.48%
30d:
-7.45%
90d:
+0.43%
BUY
HIGH Confidence
Analysis Updated: Jun 4, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When XBIT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: XBIT shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: XBIT shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: XBIT is currently trading at $2.36, which is considered oversold relative to its 30-day fair value range of $2.40 to $2.53.
Technical Outlook: Technically, XBIT is showing sideways momentum. The price is currently testing key support at $2.33. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $18.00 (+659.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, XBIT is showing sideways momentum. The price is currently testing key support at $2.33. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $18.00 (+659.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.40 -
$2.53
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 659.5% below Wall St target ($18.00)
Trading Range Analysis
30-Day Trading Range
$2.40 -
$2.53
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.34
Resistance Level
$2.48
Current Trend
Sideways
Technical data as of
Jun 3, 2026
Fundamental Context
Wall Street Target
$18.00
(+659.5%)
Revenue Growth (YoY)
-93.3%
Share & Embed Analysis
Last updated: June 05, 2026 10:55 AM ET
Data refreshes hourly during market hours. Next update: 11:55 AM
Data refreshes hourly during market hours. Next update: 11:55 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XBIT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$55 | 66 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 52 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$252 | 61 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 54 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$118 | 52 HOLD |
